Integra LifeSciences Holdings Corporation (IART) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
Integra LifeSciences Holdings Corporation (IART) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $1.16B, listed on NASDAQ, employing roughly 4,396 people, carrying a beta of 1.08 to the broader market. Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. Led by Mojdeh Poul, public since 1995-08-16.
Snapshot as of May 15, 2026.
- Spot Price
- $14.12
- ATM IV
- 67.4%
- IV Skew 25Δ
- -0.175
- IV Rank
- 15.0%
- IV Percentile
- 19.0%
- Term Structure Slope
- 0.243
As of May 15, 2026, Integra LifeSciences Holdings Corporation (IART) at-the-money implied volatility is 67.4%. IV rank is 15.0% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 19.0%. The 25-delta skew is -0.175: puts carry meaningful premium over calls, a classic equity downside-protection skew. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
IART Strategy Selection at Current Volatility Levels
For Integra LifeSciences Holdings Corporation options at 67.4% ATM IV, low IV rank (15.0%) favors premium-buying or long-vol structures: long calls or puts, debit spreads, calendar spreads, long straddles. The risk: low-rank regimes can persist for months while time decay eats premium-buyers alive. The 25-delta skew is meaningfully put-skewed, so put-credit spreads capture more premium for the same width than call-credit spreads. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
Frequently asked IART volatility skew questions
- What is the current IART ATM implied volatility?
- As of May 15, 2026, Integra LifeSciences Holdings Corporation (IART) at-the-money implied volatility is 67.4%. IV rank is 15.0% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is IART IV high or low historically?
- IV is subdued relative to its 1-year history, conditions that typically favor premium-buying strategies (long calls, long puts, debit spreads, calendar spreads).
- What does IART volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. Integra LifeSciences Holdings Corporation carries the typical equity downside-protection skew: 25-delta puts price meaningfully richer than 25-delta calls. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.